US Patent 11254912 Methods and compositions for treating cancer
Patent 11254912 was granted and assigned to CRISPR Therapeutics on February, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 23, 2021
0
Date of Patent
February 22, 2022
0
Patent Applicant
Patent Application Number
17238729
0
Patent Citations Received
Patent Inventor Names
Mary-Lee Dequéant
0
Demetrios Kalaitzidis
0
Jonathan Alexander Terrett
0
Zinkal Samir Padalia
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11254912 Methods and compositions for treating cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.